Related Experiment Videos
Complement polymorphism, the major histocompatibility complex and associated diseases: a speculation
Insights
Genetic variations in the major histocompatibility complex influence autoimmune disease susceptibility. Differences in complement component C4 activation efficiency may explain disease associations with specific gene haplotypes.
Area of Science:
- Immunogenetics
- Molecular immunology
- Autoimmunity
Background:
- Genes in the major histocompatibility complex (MHC) encode glycoproteins crucial for immune responses.
- Specific MHC haplotypes are linked to autoimmune diseases like systemic lupus erythematosus.
- Polymorphic forms of complement component C4 exhibit varying efficiencies in complement activation.
Purpose of the Study:
- To correlate MHC gene variations with autoimmune disease susceptibility.
- To investigate the role of complement component C4 (C4) functional polymorphism in disease pathogenesis.
- To understand how C4 interaction with other complement proteins influences disease risk.
Main Methods:
- Analysis of major histocompatibility complex (MHC) gene haplotypes.
- Assessment of complement component C4 (C4) polymorphism and functional activity.
- Correlating C4 efficiency with complement activation and immune complex dissolution.
Main Results:
- Different C4 polymorphic forms display varying efficiencies in activating the complement system.
- Disease susceptibility is potentially linked to the efficiency of complement-mediated cell lysis and immune aggregate dissolution.
- The strength of interaction between C4 variants and other complement proteins influences these efficiencies.
Conclusions:
- Autoimmune disease susceptibility may be influenced by the varying efficiency of complement activation and function.
- Preferential associations between certain alleles of C2, C4, factor B, and MHC class I/II antigens are suggested.
- These associations could represent potential targets for complement-mediated reactions in autoimmune diseases.
Abstract:
Genes in the major histocompatibility complex code for three major groups of glycoproteins, now referred to as classes I, II, and III. Susceptibility to some autoimmune diseases and to systemic lupus erythematosus is associated with the presence of particular haplotypes of genes in these three classes. An attempt has been made to correlate these finding on the basis of the observation that different polymorphic forms of complement component C4 show varying efficiencies of complement activation. It is suggested that susceptibility to these diseases will be related to the varying efficiency of complement cell lysis and of immune aggregate dissolution by complement. This in turn will depend on the strength of interaction of the different polymorphic forms of C4 with other proteins (some also polymorphic) in the scheme of activation and inactivation of complement. Such an arrangement would lead to preferential association of certain alleles of C2, C4 and factor B and possibly also of class I and II antigens as potential targets of complement reaction.